A Randomized Clinical Trial of Saccharomyces Cerevisiae Versus Placebo in the Irritable Bowel Syndrome

Authors

  • Dr. Amjad Atef Suliman Alhelo

Keywords:

abdominal pain, irritable bowel syndrome, probiotic saccharomyces cerevisiae, yeast

Abstract

Abstract not found

How to Cite

A Randomized Clinical Trial of Saccharomyces Cerevisiae Versus Placebo in the Irritable Bowel Syndrome. (2019). Global Journal of Medical Research, 19(F2), 1-5. https://medicalresearchjournal.org/index.php/GJMR/article/view/1703

References

Tadataka Yamada Irritable bowel syndrome, Textbook of gastroenterology. 1495-1521.

Ashton Harper, Malwina Naghibi, Davinder Garcha (2018) The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome. 7(2), 13.

Mark Pimentel, Evelyn Chow, Henry Lin (2000) Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome. 95(12), 3503-3506.

Amélie Cayzeele-Decherf, Fanny Pélerin, Sébastien Leuillet, Benoit Douillard, Béatrice Housez, Murielle Cazaubiel, Gunnard Jacobson, Peter Jüsten, Pierre Desreumaux (2017) Saccharomyces cerevisiaeCNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. 23(2), 336.

G Parkes, J Sanderson, K Whelan (2010) Treating irritable bowel syndrome with probiotics: the evidence. 69(2), 187-194.

Guillaume Pineton De Chambrun, Christel (2015) A randomized clinical trial of saccharomyces cerevisiae versus placebo in the irritable bowel syndrome. 120-124.

Quigley Em, Ohman (2012) The microbiota link to irritable bowel Syndrome: an emerging story Jeffery. 3, 572-576.

Collins Sm (2014) A role for the gut microbiota in ibs, Nature reviews gastroenterology & hepatology. 11, 497-505.

M1 Camilleri, M Choi (1997) Review article: irritable bowel syndrome. 11(1), 3-15.

Lr1 Krogsgaard, Al2 Engsbro, P Bytzer (2013) Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort. 1.

(2017) UpToDate®. 39(2), 17-17.

(2017) Treatment of irritable bowel syndrome in adults.

Daryn Michael (2017) Can taking probiotics improve well-being in females suffering from irritable bowel syndrome?.

Tanisa Patcharatrakul, Kessarin Thanapirom, Sutep Gonlachanvit (2017) Application of Rome III vs. Rome IV Diagnostic Criteria for Irritable Bowel Syndrome (IBS) in Clinical Practice: is the Newer the Better?. 152(5), S717.

Binrui Chen (2017) Reduced interstitial cells of Cajal density and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model.

A Randomized Clinical Trial of Saccharomyces Cerevisiae Versus Placebo in the Irritable Bowel Syndrome

Published

2019-03-15

How to Cite

A Randomized Clinical Trial of Saccharomyces Cerevisiae Versus Placebo in the Irritable Bowel Syndrome. (2019). Global Journal of Medical Research, 19(F2), 1-5. https://medicalresearchjournal.org/index.php/GJMR/article/view/1703